N. AKTAY AYAZ Et Al. , "Patient satisfaction and clinical effectiveness of switching from intravenous tocilizumab to subcutaneous tocilizumab in patients with juvenile idiopathic arthritis: an observational study," RHEUMATOLOGY INTERNATIONAL , vol.40, no.7, pp.1111-1116, 2020
AKTAY AYAZ, N. Et Al. 2020. Patient satisfaction and clinical effectiveness of switching from intravenous tocilizumab to subcutaneous tocilizumab in patients with juvenile idiopathic arthritis: an observational study. RHEUMATOLOGY INTERNATIONAL , vol.40, no.7 , 1111-1116.
AKTAY AYAZ, N., Karadag, S. G., Koc, R., Demirkan, F. G., ÇAKMAK, F., & SÖNMEZ, H. E., (2020). Patient satisfaction and clinical effectiveness of switching from intravenous tocilizumab to subcutaneous tocilizumab in patients with juvenile idiopathic arthritis: an observational study. RHEUMATOLOGY INTERNATIONAL , vol.40, no.7, 1111-1116.
AKTAY AYAZ, Nuray Et Al. "Patient satisfaction and clinical effectiveness of switching from intravenous tocilizumab to subcutaneous tocilizumab in patients with juvenile idiopathic arthritis: an observational study," RHEUMATOLOGY INTERNATIONAL , vol.40, no.7, 1111-1116, 2020
AKTAY AYAZ, Nuray A. Et Al. "Patient satisfaction and clinical effectiveness of switching from intravenous tocilizumab to subcutaneous tocilizumab in patients with juvenile idiopathic arthritis: an observational study." RHEUMATOLOGY INTERNATIONAL , vol.40, no.7, pp.1111-1116, 2020
AKTAY AYAZ, N. Et Al. (2020) . "Patient satisfaction and clinical effectiveness of switching from intravenous tocilizumab to subcutaneous tocilizumab in patients with juvenile idiopathic arthritis: an observational study." RHEUMATOLOGY INTERNATIONAL , vol.40, no.7, pp.1111-1116.
@article{article, author={Nuray AKTAY AYAZ Et Al. }, title={Patient satisfaction and clinical effectiveness of switching from intravenous tocilizumab to subcutaneous tocilizumab in patients with juvenile idiopathic arthritis: an observational study}, journal={RHEUMATOLOGY INTERNATIONAL}, year=2020, pages={1111-1116} }